Analysis of 160 W PVP in the treatment of benign prostatic hyperplasia of more than 80 mL
Wang Jian1, 2, Jia Zhuomin2, Ai Xing1, 2, Teng Jingfei2, Cao Zhi2
1Clinical College of General Hospital of Beijing Military Area Command, Anhui Medical University, Beijing 100700, China; 2Department of Urology, General Hospital of Beijing Military Area Command, PLA
Abstract:Objective: To evaluate the operative skills and efficacy of 160 W greenlight high performance system (HPS) laser for photoselective vaporization of prostate ( PVP) in the treatment of benign prostatic hyperplasia (BPH) of more than 80 mL. Methods: Perioperative variables of 54 patients with BPH of more than 80 mL were retrospectively analyzed. Results: All operations were performed successfully. The average operative time, postoperative catheter indwelling time and the hospital stay were (78.0±15.3) min, (3.0±1.5) days, and (5.4±1.3) days, respectively. Greatly improvement was observed in IPSS score, QOL score, Qmax score and RUV after the operation (P<0.01). There was no complication of transurethal resection syndrome and need of blood infusion during the operation. No urinary tract stenosis and urinary incontinence were observed during the follow-up period of 6 months. Conclusions: 160 W greenlight HPS laser for PVP in the treatment of BPH of more than 80 mL was favorable, effective and safter.
王健,贾卓敏,艾星,滕竞飞,曹志. 160 W绿激光治疗大体积前列腺增生的疗效分析[J]. 微创泌尿外科杂志, 2015, 4(5): 298-301.
Wang Jian, Jia Zhuomin, Ai Xing, Teng Jingfei, Cao Zhi. Analysis of 160 W PVP in the treatment of benign prostatic hyperplasia of more than 80 mL. JOURNAL OF MINIMALLY INVASIVE UROLOGY, 2015, 4(5): 298-301.
[1]Bushman W. Etiology, epidemiology, and natural history of benign prostatic hyperplasia. Urol Clin North Am, 2009,36(4):403-415. [2]Tasci AI, Ilbey YO, Tugcu V, et al. Transurethral resection of the prostate with monopolarresectoscope: single-surgeon experience and long-term results of after 3589 procedures. Urology, 2011,78(5):1151-1155. [3]Rassweiler J, Teber D, Kuntz R, et al. Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. Eur Urol, 2006,50(5):969-979. [4]Kang HW. Characterization on ablation performance of various surgical fibers. Lasers Med Sci, 2014,29(1):273-277. [5]Botto H, Lebret T, Barre P, et al. Electrovaporization of the prostate with the Gyrus device. J Endourol, 2001,15(3):313-316. [6]Te AE. The next generation in laser treatments and the role of the GreenLight high-performance system laser. Rev Urol, 2006, 8(Suppl 3):S24-S30. [7]Tam HM, Mak SK, Law MC, et al. Photoselective vaporisation prostatectomy using a GreenLight High Performance System for patients with bleeding tendency. Hong Kong Med J, 2012,18(6):502-506. [8]Karatas OF, Alkan E, Horasanli K, et al. Photoselective vaporization of the prostate in men with a history of chronic oral anti-coagulation. Int Braz J Urol, 2010,36(2):190-197. [9]Sountoulides P, Tsakiris P. The evolution of KTP laser vaporization of the prostate. Yonsei Med J, 2008,49(2):189-199. [10]王健,艾星,滕竞飞,等.绿激光汽化切除术与经尿道双极等离子电切术治疗前列腺增生的Meta分析.临床泌尿外科杂志,2015,30(9):776-782. [11]臧亚晨,单玉喜,薛波新,等.80W和120W绿激光汽化治疗高危良性前列腺增生的疗效及安全性分析.中华男科学杂志,2012,21(5):436-440. [12]Altay B, Erkurt B, Kiremit MC, et al. 180-W XPS GreenLight laser vaporization for benign prostate hyperplasia: 12-month safety and efficacy results for glands larger than 80 mL. Lasers Med Sci, 2015,30(1):317-323.